MFSD9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.80244708047894E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.43620004567202E-09 |
Normal-vs-Stage2 |
3.95760000000411E-05 |
Normal-vs-Stage3 |
2.13273843030493E-13 |
Normal-vs-Stage4 |
1.6251444634463E-12 |
Stage1-vs-Stage2 |
5.132000E-01 |
Stage1-vs-Stage3 |
8.406400E-04 |
Stage1-vs-Stage4 |
3.56620000000474E-05 |
Stage2-vs-Stage3 |
1.104580E-01 |
Stage2-vs-Stage4 |
2.414000E-02 |
Stage3-vs-Stage4 |
2.500600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.87960758069039E-12 |
Normal-vs-AfricanAmerican |
4.25780000146148E-09 |
Normal-vs-Asian |
1.389830E-01 |
Caucasian-vs-AfricanAmerican |
5.970800E-01 |
Caucasian-vs-Asian |
2.697400E-01 |
AfricanAmerican-vs-Asian |
1.825220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.16493489801906E-14 |
Normal-vs-Female |
2.36429997801935E-09 |
Male-vs-Female |
6.548300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.50462999999323E-05 |
Normal-vs-Age(41-60Yrs) |
5.35926858447056E-12 |
Normal-vs-Age(61-80Yrs) |
3.73823194621536E-12 |
Normal-vs-Age(81-100Yrs) |
2.40569999999662E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.363200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.160200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.956600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.367000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.455400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.210400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.544400E-02 |
Normal-vs-Grade 2 |
8.44989966886089E-10 |
Normal-vs-Grade 3 |
9.04665231615809E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
4.061000E-01 |
Grade 1-vs-Grade 3 |
2.205800E-01 |
Grade 1-vs-Grade 4 |
2.322300E-03 |
Grade 2-vs-Grade 3 |
1.985830E-01 |
Grade 2-vs-Grade 4 |
4.6862999999453E-06 |
Grade 3-vs-Grade 4 |
1.098250E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.94700000011316E-07 |
Normal-vs-ccB subtype |
2.17226236998158E-12 |
ccA subtype-vs-ccB subtype |
5.396600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.73801031531229E-12 |
Normal-vs-N1 |
5.557600E-04 |
N0-vs-N1 |
9.989600E-01 |
|
|